| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Maximising Your Communication When Replying to Emails |
|
Advice You - Maximising Your Communication When Replying to Emails
Answering emails has the same importance as answering telephone message According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product s.
Usually an email may more usefully be replied to with a phone call ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in rather than another email (think about that) Emails need to be lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. sorted into priorities; • “For your information” emails can be filed here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe without answering. • “Requests for information and service” emails nee d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro d to be addressed early, especially if from a customer (or manager). • ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc General and personal communications can be responded to last. • Where easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi someone has carried out a request which we made of them, then good man nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ners requires that we respond with a short and simple thank you, just a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ s if we were talking to them - as soon as we receive their email. As w ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e noted in a previous article; if we are about to reply to an email in ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a a manner that could start electronic warfare, then picking up the telep dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod hone and talking to them is a better option. However, if we are respon cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ding to the sender of a company wide email, rest assured that every mem tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ber of the organisation does not want to have to read our reply, no mat t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ter how witty or urbane we may think it is. This applies to personal e- ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust mail (especially if it's an Internet joke or rumor). So the “reply all” y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products option is a general no-go option. When replying to emails, the common . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de courtesy is to put the reply at the top with the original email undern elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip eath. This gives the reader less to plough through to get our response. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Five Reasons You Were Rejected for the Job You Thought You Had
|